A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a...

por Kümler, Iben, Balslev, Eva, Stenvang, Jan, Brünner, Nils, Nielsen, Dorte
Publicado 2015

Specific CDK4/6 inhibition in breast cancer: a systematic review of current clinical evidence

por Polk, Anne, Kolmos, Ida Lykke, Kümler, Iben, Nielsen, Dorte Lisbeth
Publicado 2017

Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant

por Kümler, Iben, Knoop, Ann S, Jessing, Christina A R, Ejlertsen, Bent, Nielsen, Dorte L
Publicado 2016

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase...

por Kümler, Iben, Balslev, Eva, Stenvang, Jan, Brünner, Nils, Ejlertsen, Bent, Jakobsen, Erik Hugger, Nielsen, Dorte Lisbet
Publicado 2019

Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development

por Stenvang, Jan, Kümler, Iben, Nygård, Sune Boris, Smith, David Hersi, Nielsen, Dorte, Brünner, Nils, Moreira, José M. A.
Publicado 2013

Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer

por Celik, Alan, Berg, Tobias, Jensen, Maj-Britt, Jakobsen, Erik, Nielsen, Hanne Melgaard, Kümler, Iben, Glavicic, Vesna, Jensen, Jeanette Dupont, Knoop, Ann
Publicado 2023

Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast Cancers

por Thagaard, Jeppe, Stovgaard, Elisabeth Specht, Vognsen, Line Grove, Hauberg, Søren, Dahl, Anders, Ebstrup, Thomas, Doré, Johan, Vincentz, Rikke Egede, Jepsen, Rikke Karlin, Roslind, Anne, Kümler, Iben, Nielsen, Dorte, Balslev, Eva
Publicado 2021